Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAA| |TTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCT
End
55742998/55515862 (Hg38)
Nearest miRNA
hsa-mir-1301/Upstream/1666657; hsa-mir-10b/Downstream/467105;
Upstream sequence
atagcagtcctagcaaactaatacaCcatttaaaagagggagaaaatcttaatatcatctttatttagctcacaagtttgctgtaagtcaaatagatgta
Downstream sequence
atctctttgtaaactgtaaagtactatataaatgtgaataattgttattCACAAGGTCCTTGAAAATGCAGTCATGTTGTTACGATTTGAATTTTATATT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.